Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $71.47 ($1.8M) on 2019-09-17, disclosed to the SEC on 2019-09-19.
Scheduled sale ($1.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |
| GHDX | SELL | 2019-06-13 | $5.1M | — | Filing → |